Background: Stroke is one of the root causes of brain disorders at the height of the productive age and ranks second cause of death after heart disease in most countries in the world. Fairly large-scale study conducted by ASNA (ASEAN Neurological Association) in 28 Hospitals in Indonesia. This study was conducted in patients with acute stroke who were treated in hospital (hospital-based study) and conducted a survey of factors -risk factors, treatment duration and mortality and morbidity. Method: This is a cross sectional study, with intracerebral hemorrhage Head CT scan examination then examined serum levels of plasma GFAP her at the time of patient entry from RSUP. H. Adam Malik Medan from March 2014 -May 2014. Results: In this research, we found the frequency of male patients as many (62.5%), while as many women (37.5%). Predominant age range in patients encountered in this study were 46-51 years old and are the dominant ethnic Batak tribe (43.8%). Conclusion: There were no significant differences between groups in serum GFAP levels with bleeding volume ≥ 30 cc compared to those with bleeding volume <30 cc (p = 0.599). GFAP is a biomarker to distinguish whether stroke patients including intracerebral hemorrhage or ischemic stroke Further longitudinal study would be needed to confirm the role. 
INTRODUCTION
Stroke is one of the causes of brain disorders at the height of the productive age and ranks second cause of death after heart disease in most countries in the world. Fairly large-scale study conducted by ASNA (ASEAN Neurological Association) in 28 Hospitals in Indonesia. This study was conducted in patients with acute stroke who were treated in hospital (hospital-based study) and conducted a survey of factors -risk factors, treatment duration and mortality and morbidity. The results showed that patients with more men than women with a profile under 45 years of age in quite a lot of that is 11.8%, age 45-64 years amounted to 54.7% and over the age of 65 years 33.5%. Neurological biomarkers showed clinically significant in some circumstances include head injury, anoxia, subarachnoid bleeding and ischemic stroke. Biological markers are also very useful in cases of acute stroke. Examination of blood samples examined by a particular method allows to quickly differentiate ischemic stroke and intracerebral hemorrhage in order to provide the possibility for immediate intervention. Furthermore, biological markers may provide prognostic information and may identify patients who have a high risk of side effects specific therapy. Glial fibrillary acidic protein (GFAP) is a specific protein filament in the brain which appears immediately on astrocytes. The new examination identified as a biological marker of intracerebral hemorrhage in the acute phase of stroke. Has an important role in maintaining the size and motility of astrocytic processes and contribute to the structure of white matter, myelination and integrity of the blood brain barrier. High levels of GFAP are found in specific parts of the brain.
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METHODS
The research methodology was cross sectional, with intracerebral hemorrhage Head CT scan examination then examined serum levels of plasma GFAP her at the time of patient entry from RSUP. H. Adam Malik Medan from March 2014 -May 2014. The BC patients must fulfill the criteria: Patients who suffer from ICH all sexes, aged adult (over 18 years), when the incident until arriving at the hospital less than 48 hours, the patient came directly from the scene and has not received any treatment, and the results of a CT scan of the brain of ICH. T-Test analysis was performed between those variable (GFAP levels with bleeding volume ≥ 30 cc compared to those with bleeding volume <30 cc) with p value of 0,005.
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RESULT
In this research, we found the frequency of male patients as many (62.5%), while as many women (37.5%). Predominant age range in patients encountered in this study were 46-51 years old and are the dominant ethnic Batak tribe (43.8%).
14 From this study it was found that the location of bleeding most is the Basal Ganglia (34.3%). There are significant differences in serum GFAP levels among groups with ≥ 30 cc volume of bleeding compared to those with bleeding volume <30 cc (p = 0.599). This research also obtained mortality rate is high enough that as many as 19 research subjects died (59.4%) and only 13 research subjects who survived (40.6%). The results of this study are expected to become an input for further research that will be useful for the treatment of patients with intracerebral hemorrhage. [15] [16] [17] From this study it was found that the location of bleeding most is the Basal Ganglia (34.3%). There are significant differences in serum GFAP levels among groups with ≥ 30 cc volume of bleeding compared to those with bleeding volume <30 cc (p = 0.599). This research also obtained mortality rate is high enough that as many as 19 research subjects died (59.4%) and only 13 research subjects who survived (40.6%). The results of this study are expected to become an input for further research that will be useful for the treatment of patients with intracerebral hemorrhage.
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CONCLUSIONS
There were no significant differences between groups in serum GFAP levels with bleeding volume ≥ 30 cc compared to those with bleeding volume <30 cc (p = 0.599). GFAP is a biomarker to distinguish whether stroke patients including intracerebral hemorrhage or ischemic stroke Further longitudinal study would be needed to confirm thus role.
